Eye Disease News and Research

RSS

Eye diseases are widespread around the globe. According to the World Health Organization, the most important three eye diseases or conditions that are a potential threat to the global population are diabetic retinopathy, glaucoma, and age-related macular degeneration. One more vital reason for visual harm is refractive errors. Some of the important reasons for vision loss or low vision are age, healthcare, gender, genetic problems and the prevalence of family history.

First steps taken to treat human hereditary blindness

A team led by Krzysztof Palczewski, Ph.D., chair of pharmacology at the Case Western Reserve University School of Medicine, has taken the first steps in treating an eye disease causing irreversible congenital blindness in millions of people worldwide by successfully testing two new treatments in mice.

3 Nov 2005

Treatment for Leber Congenital Amaurosis

U.S. researchers have taken the first steps in treating an eye disease that causes irreversible blindness in humans by successfully testing two novel treatments in mice.

1 Nov 2005

Fatty acids in the diet may play a key role in dry eye syndrome

More than eight million people in the United States, predominantly women, suffer from dry eye syndrome, a painful and debilitating eye disease.

19 Oct 2005

New glaucoma risk calculator

High eye pressure is the leading risk factor for glaucoma, and is the only modifiable one. If glaucoma is untreated, vision loss may continue, leading to blindness in some individuals.

17 Oct 2005

First-of-its-kind test on a microchip array will help diagnose retinitis pigmentosa

Rapid genetic testing for eye disease is becoming a reality, thanks to a technology developed at the University of Michigan Kellogg Eye Center.

19 Sep 2005

Immune cells known as macrophages linked to growth of lymph vessels in eyes,

Scientists at Schepens Eye Research Institute have discovered that a particular immune cell contributes to the growth of new lymph vessels, which aid in healing. This cell, known as a macrophage, is called in by the body during the wound healing process.

6 Sep 2005

Immunosuppressive drug mycophenolate mofetil may be effective in controlling inflammatory eye diseases

The immunosuppressive drug mycophenolate mofetil, used to prevent rejection of transplanted hearts, kidneys and livers, may also be effective in controlling inflammatory eye diseases, according to a study by Johns Hopkins' Wilmer Eye Institute.

4 Sep 2005

Scientists use gene transfer to prevent retinoschisis

University of Florida scientists used a healthy human gene to prevent blindness in mice with a form of an incurable eye disease that strikes boys.

2 Aug 2005

New compound ruboxistaurin may decrease vision loss in diabete

A multicenter international study chaired by a Joslin Diabetes Center investigator and reported in the July issue of the American Diabetes Association's journal Diabetes brings hopeful news to the 18 million people in the United States -- and millions more worldwide -- with type 1 or type 2 diabetes.

15 Jul 2005

Patients with newly diagnosed type 2 diabetes should be screened for retinopathy

Diabetic retinopathy has been found in nearly 8 percent of pre-diabetic participants in the Diabetes Prevention Program (DPP), according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions.

12 Jun 2005

Major advances in the global fight against eye disease

Now research offering a better understanding of the genetics controlling endemic eye diseases will be advanced by an international collaboration between Cardiff University’s School of Optometry and Vision Sciences and the Department of Opthalmology, Kyoto Prefectural University of Medicine, Japan.

6 Jun 2005

Allergies increase risk for corneal transplant rejection

Corneal transplant patients who suffer from eye allergies are at a significantly higher risk of transplant failure than those without allergies, UT Southwestern Medical Center researchers have shown.

22 May 2005

Older adults with diabetes in managed care networks have higher rates of untreated eye disease

Medicare beneficiaries at high risk for eye disease due to diabetes are more likely to have unrecognized and untreated eye disease if they are enrolled in managed care than if they have fee-for-service (FFS) health insurance, according to an article in the May issue of Archives of Ophthalmology.

9 May 2005

New laser-surgery technique to perform cornea-transplant surgery

A UC Irvine ophthalmologist and his team have invented a new laser-surgery technique to perform cornea-transplant surgery that can replace the use of traditional handheld surgical blades and potentially improve recovery time for patients.

3 May 2005

Glaucoma therapy patients often do not comply with their doctor’s prescribed medicine regimen

A study that appears in the May edition of Ophthalmology, the clinical journal of the American Academy of Ophthalmology, shows that as many as 47 percent of patients receiving glaucoma therapy do not comply with their doctor’s prescribed medicine regimen. This is in startling contrast to the 90 percent of doctors who believe that their patients are following the prescribed treatment.

2 May 2005

Researchers present information on artificial retina

Researchers from the University of Southern California and the Doheny Eye Institute will be presenting data on the first six patients implanted with an intraocular retinal prosthesis-more popularly referred to as an artificial retina-developed and manufactured in partnership with Second Sight Medical Products, of Sylmar, Calif.

2 May 2005

Glaucoma therapy recipients do not comply with doctor's prescribed medicine regimen

A study that appears in the May edition of Ophthalmology, the clinical journal of the American Academy of Ophthalmology, shows that as many as 47 percent of patients receiving glaucoma therapy do not comply with their doctor's prescribed medicine regimen. This is in startling contrast to the 90 percent of doctors who believe that their patients are following the prescribed treatment.

1 May 2005

Study shows older children also benefit from lazy eye treatment

Researchers at the Johns Hopkins Children's Center and 48 eye centers across North America report that many children between the ages of 7 and 17 with amblyopia, or "lazy eye," may benefit from treatments usually prescribed for younger children.

11 Apr 2005

Preventing eye disease in retinitis pigmentosa

Retinitis pigmentosa (RP) is an inherited eye disease that causes visual disability leading to blindness. Over the last 15 years, researchers have pinpointed defects in dozens of genes causing different forms of RP.

22 Mar 2005

Gene identified that confers susceptibility to age-related macular degeneration

By combining the tools of high-throughput biology and statistical genetics, scientists at Rockefeller University, Yale University School of Public Health and the National Eye Institute have identified a gene that confers susceptibility to age-related macular degeneration (AMD), the most common cause of vision loss in the United Sates for those over 60.

14 Mar 2005